The 1989 Lasker Award Affirms The Value Of Contraceptive Research

The Albert Lasker Clinical Medical Research Awards are certainly prestigious; indeed, they are widely regarded as comparable to the Nobel Prize. Since the Lasker awards were established in 1946, 48 winners have later been awarded Nobels, including J. Michael Bishop and Harold E. Varmus, University of California, San Francisco, who share this year’s prize in medicine for their breakthrough research on oncogenes. I take pride, incidentally, in our forecast of their recognition in the Octobe

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The Albert Lasker Clinical Medical Research Awards are certainly prestigious; indeed, they are widely regarded as comparable to the Nobel Prize. Since the Lasker awards were established in 1946, 48 winners have later been awarded Nobels, including J. Michael Bishop and Harold E. Varmus, University of California, San Francisco, who share this year’s prize in medicine for their breakthrough research on oncogenes. I take pride, incidentally, in our forecast of their recognition in the October 2 issue of The Scientist (D. Pendlebury, “The 1989 Nobel Prize In Medicine: 20 Who Deserve It,” page 14).

The 1989 Lasker award was presented to Etienne-Emile Baulieu, University of Paris-Sud, for his research on steroid hormones, which has led to the development of RU486, an oral medication that terminates pregnancy.

By honoring Baulieu’s work, the Lasker jury has made a strong statement affirming the value of contraceptive research in general and RU486 in particular. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Eugene Garfield

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo